Precigen

PGEN

Precigen, Inc (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

Precigen has been a target of short sellers for a while. The current short interest of 11.83% is roughly at the average of the last 12 months (10.79%).